HIV molecular immunology database

 

Search Antibody Database

Found 1 matching record:

Displaying record number 1827

Download this epitope record as JSON.

MAb ID P1H6
HXB2 Location gp160(143-148)
DNA(6651..6668)
gp160 Epitope Map
Author Location gp120( SF162)
Research Contact Nina Derby or Leo Stamatatos, Seattle Biomedical Research Institute, Seattle, WA, USA, leo.stamatotos@sbri.org
Epitope SSNWKE Epitope Alignment
SSNWKE epitope logo
Subtype B
Ab Type gp120 V1
Neutralizing  
Species (Isotype) mouse(IgG1κ)
Patient  
Immunogen vaccine
Country United States
Keywords antibody binding site, neutralization

Vaccine Details

Vaccine type DNA prime with protein boost
Vaccine strain B clade SF162
Vaccine component gp140ΔV2

Notes

Showing 2 of 2 notes.

References

Showing 2 of 2 references.

Isolation Paper
Derby2007 Nina R. Derby, Sean Gray, Elizabeth Wayner, Dwayne Campogan, Giorgos Vlahogiannis, Zane Kraft, Susan W. Barnett, Indresh K. Srivastava, and Leonidas Stamatatos. Isolation and Characterization of Monoclonal Antibodies Elicited by Trimeric HIV-1 Env gp140 Protein Immunogens. Virology, 366(2):433-445, 30 Sep 2007. PubMed ID: 17560621. Show all entries for this paper.

Ching2008 Lance K. Ching, Giorgos Vlachogiannis, Katherine A. Bosch, and Leonidas Stamatatos. The First Hypervariable Region of the gp120 Env Glycoprotein Defines the Neutralizing Susceptibility of Heterologous Human Immunodeficiency Virus Type 1 Isolates to Neutralizing Antibodies Elicited by the SF162gp140 Immunogen. J. Virol., 82(2):949-956, Jan 2008. PubMed ID: 18003732. Show all entries for this paper.


Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health